Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hoskin

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 14, 2018
Short-term Toxicity of High Dose Rate Brachytherapy in Prostate Cancer Patients with Inflammatory Bowel DiseaseW Mohammed, P Hoskin, A Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapyP Hoskin, S Dilly, D Easton, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 12, 2020
Clinical Guidance for the Management of Patients with Urothelial Cancers During the COVID-19 Pandemic - Rapid ReviewK Patel, A Choudhury, P Hoskin, et al.
Indian Journal of Cancer|March 11, 2016
Hypofractionated radiotherapy for localized prostate cancer using three-dimensional conformal radiotherapy technique: 3 years toxicity analysisR White, D Woolf, S Li, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 2026
Predicting High-Dose-Rate Brachytherapy Boost Benefit Using Hypoxia and Angiogenesis Gene Expression in Localised Prostate CancerT Lodhi, M Reardon, C G Quiles, et al.
British Journal of Cancer|March 18, 2004
Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphomaJ Spicer, P Smith, K Maclennan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 26, 2017
High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: Review of the Current StatusN Tselis, P Hoskin, D Baltas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2018
Management of cancer pain in adult patients: ESMO Clinical Practice GuidelinesM Fallon, R Giusti, F Aielli, et al.
British Journal of Cancer|July 1, 1996
Nicotinamide pharmacokinetics in humans: effect of gastric acid inhibition, comparison of rectal vs oral administration and the use of saliva for drug monitoringM R Stratford, M F Dennis, P Hoskin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 10, 2023
Improving Quality of Life with Brachytherapy for Urological MalignanciesD Scheltes, S Mohanty, G Smits, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 14, 2018
Short-term Toxicity of High Dose Rate Brachytherapy in Prostate Cancer Patients with Inflammatory Bowel DiseaseW Mohammed, P Hoskin, A Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapyP Hoskin, S Dilly, D Easton, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 12, 2020
Clinical Guidance for the Management of Patients with Urothelial Cancers During the COVID-19 Pandemic - Rapid ReviewK Patel, A Choudhury, P Hoskin, et al.
Indian Journal of Cancer|March 11, 2016
Hypofractionated radiotherapy for localized prostate cancer using three-dimensional conformal radiotherapy technique: 3 years toxicity analysisR White, D Woolf, S Li, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 2026
Predicting High-Dose-Rate Brachytherapy Boost Benefit Using Hypoxia and Angiogenesis Gene Expression in Localised Prostate CancerT Lodhi, M Reardon, C G Quiles, et al.
British Journal of Cancer|March 18, 2004
Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphomaJ Spicer, P Smith, K Maclennan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 26, 2017
High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: Review of the Current StatusN Tselis, P Hoskin, D Baltas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2018
Management of cancer pain in adult patients: ESMO Clinical Practice GuidelinesM Fallon, R Giusti, F Aielli, et al.
British Journal of Cancer|July 1, 1996
Nicotinamide pharmacokinetics in humans: effect of gastric acid inhibition, comparison of rectal vs oral administration and the use of saliva for drug monitoringM R Stratford, M F Dennis, P Hoskin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 10, 2023
Improving Quality of Life with Brachytherapy for Urological MalignanciesD Scheltes, S Mohanty, G Smits, et al.
Pageof 9